Cover Image

HARDBACK
$52.95



View/Hide Left Panel

Biotechnology, 26, 30, 33–34, 90, 379, 381–386

attenuated live viruses, 19, 20, 24–25, 328–329, 352, 379

Epstein-Barr virus, 332–333, 334

hepatitis B virus, 18, 379

hepatitis C virus, 337

herpes simplex virus, 327–328

Histoplasma capsulatum 358

hybridoma, 30

monoclonal antibodies, 29–30

mycobacterium tuberculosis, 355

papillomaviruses, 339–340

risk capital, 125

Salmonella, 31–32

see also DNA; Genomes; RNA

Bordetella pertussis, 11, 18, 19, 20, 28, 30, 46

Borrelia burgdorferi, 7, 44, 54, 88, 91, 100, 143–148

Burkitt’s lymphoma, 330, 331, 332, 333

C

Canada, 49, 62, 66, 68, 96, 99

Cancer, 1, 12, 185, 189, 190, 194, 213–219, 381, 411, 415–433

autoimmune therapy, 427–429, 431

Epstein-Barr virus, 330–333

melanoma, 6, 54, 88, 89–90, 239–243, 421

papillomaviruses, 338–342

Caribbean region, 343

Centers for Disease Control and Prevention, 14, 28, 50, 100, 125, 126

Central nervous system, 67, 399–403

herpes simplex virus, 196–200 (passim), 202, 204, 328

multiple sclerosis, 6, 35, 54, 87, 245–249, 397, 399–400

see also Neisseria meningitidis

Children, 7, 8–9, 45–47, 60, 69, 72, 80–82, 91, 99, 100, 101, 111, 130, 377

American Academy of Pediatrics, 45, 126

CDC recommendations, 28

chlamydia, 6, 88, 157

combination vaccines, 9, 18, 38, 46–47, 75, 130

contraceptive vaccines, health effects, 76

cytomegalovirus, 6, 90, 167

dengue virus, 343, 345

Epstein-Barr virus, 7, 88, 177, 179, 330–331, 333

gonorrhea, 6, 88

Helicobacter pylori, 181

herpes simplex virus, 6, 88, 196, 203, 329

influenza virus, 223–224

liability issues, 128–129

meningitis, 267

National Childhood Vaccine Injury Act, 20–21, 128–129, 258

papillomaviruses, 6, 88, 219, 342

pregnant, 51

polio, 24

record-keeping, 46, 47, 49

respiratory syncytial virus, 88, 279, 280, 281

rotavirus, 291–292

school entry immunizations, 7, 8–9, 20, 49, 90, 130

Shigella, 295

streptococcus, group A, 299, 363

streptococcus, group B, 6, 93, 310, 311–312

Streptococcus pneumoniae 313, 314, 315

Vaccines for Children Program, 47, 131

see also Infants

Children’s Vaccine Initiative, 127–128

China, 334

Chlamydia, 6, 54, 67, 88, 89–90, 97, 149–158, 347–351, 368

Cholera, see Vibrio cholerae

Clinical trials, 9, 19, 70, 105, 126, 406, 417, 424, 430–431, 436

djuvants, 373, 374

AIDS, 373, 379

Bordetella pertussis, 30



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement